Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II.
- 1 June 1989
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 13 (6_pt_2) , 749-753
- https://doi.org/10.1161/01.hyp.13.6.749
Abstract
The direct effects of a renin inhibitor, N-acetyl-pepstatin and five angiotensin converting enzyme inhibitors, captopril and the active diacid forms of enalapril, ramipril, cilazapril, and CS-622, on the vascular renin-angiotensin system were examined in isolated perfused rat mesenteric arteries. Vascular renin activity and angiotensin II (Ang II) released into the perfusate were determined. Infusion of N-acetyl-pepstatin (5 X 10(-8)-5 X 10(-6) M) suppressed vascular renin activity and Ang II release dose dependently. Isoproterenol (10(-6) M) induced a 135 +/- 30% increase in Ang II release from the basal value. N-Acetyl-pepstatin (5 X 10(-6) M) suppressed isoproterenol-induced Ang II release. Infusions of 5 X 10(-6) M captopril and the diacid forms of enalapril, ramipril, cilazapril, and CS-622 by themselves had little effect on Ang II release, but concomitant infusion of isoproterenol with these angiotensin converting enzyme inhibitors significantly decreased Ang II release (71 +/- 21%, 51 +/- 40%, 8 +/- 21%, 69 +/- 24%, and 44 +/- 29% increase, respectively, from the basal values). These results indicate that N-acetyl-pepstatin suppresses the vascular renin-angiotensin system. This effect may in part contribute to the hypotensive actions of renin inhibitors. Although angiotensin converting enzyme inhibitors also suppress locally generated Ang II, the mechanism and physiological significance still remain to be clarified.Keywords
This publication has 20 references indexed in Scilit:
- Local generation and release of angiotensin II in peripheral vascular tissue.Hypertension, 1988
- Regulation of angiotensin converting enzyme activity in cultured human vascular endothelial cellsBiochemical and Biophysical Research Communications, 1987
- Plasma angiotensins and blood pressure during converting enzyme inhibition.Hypertension, 1987
- Circulating and tissue angiotensin systems.Journal of Clinical Investigation, 1987
- An orally active inhibitor of renin.Hypertension, 1986
- Significance of the vascular renin-angiotensin pathway.Hypertension, 1986
- Effect of acute oral administration of captopril and MK-421 on vascular angiotensis converting enzyme activity in the spontaneously hypertensive ratLife Sciences, 1983
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978